跳至主要内容
临床试验/JPRN-UMIN000006930
JPRN-UMIN000006930已完成未知

Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI) study on anticoagulant therapy in nonvalvular atrial fibrillation (NVAF) - SAMURAI-NVAF Study

ational Cerebral and Cardiovascular Center0 个研究点目标入组 1,192 人开始时间: 2011年12月22日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,192

研究概览

简要总结

PUBLICATIONS Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: The SAMURAI-NVAF Study. Int J Stroke. 2015; 10: 836-842. Three-month risk-bene t pro le of anticoagulation after stroke with atrial brillation: The SAMURAI-NVAF study. Int J Stroke 2016; 11: 565-574. Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation-SAMURAI-NVAF Study. Circ J. 2018 Jun 25;82(7):1935-1942

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Rheumatic mitral valve disease 2.A history of prosthetic valve replacement or mitral valve surgical repair 3.Active infective endocarditis 4.Patient, family member or legally responsible person does not have given informed consent 5.Inappropriate patient's conditions for study enrollment in the opinion of the investigator

研究者

发起方
ational Cerebral and Cardiovascular Center

相似试验